EZH2 and gastric cancer: For instance, lncRNA GATA6-AS1 reduces FZD4 expression by recruiting EZH2 and H3K27me3 to the FZD4 promoter region, thereby inactivating the Wnt/β-catenin signaling pathway and ultimately inhibiting GC progression [35].